» Articles » PMID: 38106991

A Risk Signature Based on Endoplasmic Reticulum Stress-associated Genes Predicts Prognosis and Immunity in Pancreatic Cancer

Overview
Specialty Biology
Date 2023 Dec 18
PMID 38106991
Authors
Affiliations
Soon will be listed here.
Abstract

The involvement of endoplasmic reticulum (ER) stress in cancer biology is increasingly recognized, yet its role in pancreatic cancer (PC) remains unclear. This study aims to elucidate the impact of ER stress on prognosis and biological characteristics in PC patients. A bioinformatic analysis was conducted using RNA-seq data and clinicopathological information from PC patients in the TCGA and ICGC databases. The ER stress-associated gene sets were extracted from MSigDB. ER stress-associated genes closely linked with overall survival (OS) of PC patients were identified via log-rank test and univariate Cox analysis, and further narrowed by LASSO method. A risk signature associated with ER stress was formulated using multivariate Cox regression and assessed through Kaplan-Meier curves, receiver operating characteristic (ROC) analyses, and Harrell's concordance index. External validation was performed with the ICGC cohort. The single-sample gene-set enrichment analysis (ssGSEA) algorithm appraised the immune cell infiltration landscape. Worse OS in PC patients with high-risk signature score was observed. Multivariate analysis underscored our ER stress-associated signature as a valuable and independent predictor of prognosis. Importantly, these results based on TCGA were further validated in ICGC dataset. In addition, our risk signature was closely associated with homeostasis, protein secretion, and immune regulation in PC patients. In particular, PC microenvironment in the high-risk cluster exhibited a more immunosuppressive status. At last, we established a nomogram model by incorporating the risk signature and clinicopathological parameters, which behaves better in predicting prognosis of PC patients. This comprehensive molecular analysis presents a new predictive model for the prognosis of PC patients, highlighting ER stress as a potential therapeutic target. Besides, the findings indicate that ER stress can have effect modulating PC immune responses.

Citing Articles

Glutathione‑degrading enzymes in the complex landscape of tumors (Review).

Zhang T, Yao C, Zhou X, Liu S, Qi L, Zhu S Int J Oncol. 2024; 65(1).

PMID: 38847236 PMC: 11173371. DOI: 10.3892/ijo.2024.5660.


The Integrated Stress Response in Pancreatic Development, Tissue Homeostasis, and Cancer.

Malnassy G, Ziolkowski L, Macleod K, Oakes S Gastroenterology. 2024; 167(7):1292-1306.

PMID: 38768690 PMC: 11570703. DOI: 10.1053/j.gastro.2024.05.009.

References
1.
Liu C, Hsu C, Huang T, Lee C, Chen J, Yang S . ER stress-related ATF6 upregulates CIP2A and contributes to poor prognosis of colon cancer. Mol Oncol. 2018; 12(10):1706-1717. PMC: 6166000. DOI: 10.1002/1878-0261.12365. View

2.
Park D, Sung P, Kim J, Lee G, Jang J, Jung E . EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer. 2020; 8(1). PMC: 7206970. DOI: 10.1136/jitc-2019-000301. View

3.
Pan H, Yang L, Bai H, Luo J, Deng Y . Ginsenoside Rg3 increases gemcitabine sensitivity of pancreatic adenocarcinoma via reducing ZFP91 mediated TSPYL2 destabilization. J Ginseng Res. 2022; 46(5):636-645. PMC: 9459078. DOI: 10.1016/j.jgr.2021.08.004. View

4.
Harnoss J, Le Thomas A, Reichelt M, Guttman O, Wu T, Marsters S . IRE1α Disruption in Triple-Negative Breast Cancer Cooperates with Antiangiogenic Therapy by Reversing ER Stress Adaptation and Remodeling the Tumor Microenvironment. Cancer Res. 2020; 80(11):2368-2379. PMC: 7272310. DOI: 10.1158/0008-5472.CAN-19-3108. View

5.
Kang H, Choi M, Kim S, Jeong J, Kwon A, Kim T . and as Candidate Prognostic Markers for Advanced-Stage High-Grade Serous Ovarian Carcinoma. Cancers (Basel). 2021; 13(16). PMC: 8391231. DOI: 10.3390/cancers13163976. View